Evidence map›Paper›PMID 33447913›Full record

ArticleEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology2021

Clinical characteristics of re-hospitalized COVID-19 patients with recurrent positive SARS-CoV-2 RNA: a retrospective study.

Lei Pan, Runsheng Wang, Na Yu, Chao Hu, Junhong Yan, Xiaomin Zhang, Tao Wang, Jungui Hao, Fuquan Gao, Tonggang Liu and 10 more

Abstract read
In one paragraph

Article in European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Lei Pan *Department of Respiratory and Critical Care Medicine, Binzhou Medical University Hospital, Binzhou, China.
Runsheng Wang *Department of Respiratory Medicine, The Second Medical Center & National Clinical Research Center for Geriatric Diseases, Medical College of PLA, Chinese PLA General Hospital, Beijing, China.
Na Yu *Department of Gynecology, Shandong Provincial Third Hospital, Jinan, China.
Chao Hu *Department of Respiratory Medicine, The Second Medical Center & National Clinical Research Center for Geriatric Diseases, Medical College of PLA, Chinese PLA General Hospital, Beijing, China.
Junhong YanDepartment of Ultrasound, Binzhou Medical University Hospital, Binzhou, China.
Xiaomin ZhangDepartment of Nephrology, Binzhou Medical University Hospital, Binzhou, China.
Tao WangDepartment of Respiratory and Critical Care Medicine, Binzhou Medical University Hospital, Binzhou, China.
Jungui HaoDepartment of Infection Diseases, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.
Fuquan GaoDepartment of Respiratory and Critical Care Medicine, Binzhou Medical University Hospital, Binzhou, China.
Tonggang LiuDepartment of Infectious Diseases, Binzhou Medical University Hospital, Binzhou, China.
Jing WangDepartment of Respiratory and Critical Care Medicine, Binzhou Medical University Hospital, Binzhou, China.
Xiaojing LiuDepartment of Respiratory and Critical Care Medicine, Binzhou Medical University Hospital, Binzhou, China.
Mi MuDepartment of Disease Prevention and Control, The Second Medical Center & National Clinical Research Center for Geriatric Diseases, Chinese PLA General Hospital, Beijing, China.
Wei HuangDepartment of Infection Diseases, Huanggang Central Hospital, Huanggang, China.
Yongzhong GuoDepartment of Respiratory Medicine, Xuzhou Central Hospital, The Xuzhou School of Clinical Medicine of Nanjing Medical University, Xuzhou Clinical School of Xuzhou Medical University, Xuzhou, China.
Changjun LvDepartment of Respiratory and Critical Care Medicine, Binzhou Medical University Hospital, Binzhou, China.
Xiaozhi Wang *Department of Respiratory and Critical Care Medicine, Binzhou Medical University Hospital, Binzhou, China. bzyxy3013@163.com.
Lei Tu *Division of Gastroenterology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. tulei_1985@126.com.
Kun Wan *Medical Supplies Center, Chinese PLA General Hospital, Beijing, China. 301wk@sina.com.
Guogang Xu *The Second Medical Center & National Clinical Research Center for Geriatric Diseases, Chinese PLA General Hospital, Beijing, China. guogang_xu@163.com.

Funding

Health and Family Planning Commission of Shandong Province CN, 2017WS366National Natural Science Foundation of China CN, 81700490Technology Plan Project of Binzhou Medical University CN, BY2017KJ30
6 · The paper itself

Abstract

At present, it has been noticed that some patients recovered from COVID-19 present a recurrent positive RNA test of SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) after being discharged from hospitals. The purpose of the current study was to characterize the clinical features of re-hospitalized patients with recurrent SARS-CoV-2 positive results. From January 12 to April 1 of 2020, our retrospective study was conducted in China. The exposure history, baseline data, laboratory findings, therapeutic schedule, and clinical endpoints of the patients were collected. All the patients were followed until April 10, 2020. Among all COVID-19 patients included in the current study, there were 14 re-hospitalized patients due to recurrent positive tests of SARS-CoV-2 RNA. Fever (11 [78.6%]), cough (10 [71.4%]), and fatigue (7 [50.0%]) were the most common symptoms on the patient's first admission, and less symptoms were found on their second admission. The average duration from the onset of symptoms to admission to hospital was found to be 8.4 days for the first admission and 2.6 days for the second admission (P = 0.002). The average time from the detection of RNA (+) to hospitalization was 1.9 days for the first admission and 2.6 days for the second admission (P = 0.479), and the average time from RNA (+) to RNA (-) was 11.1 days for the first admission and 6.3 days for the second admission (P = 0.030). Moreover, the total time in hospital was 18.6 days for the first admission and 8.0 days for the second admission (P = 0.000). It may be necessary to increase the isolation observation time and RT-PCR tests should be timely performed on multiple samples as soon as possible.

Indexed as

Patient ReadmissionAdultAgedChinaCoughCOVID-19COVID-19 Nucleic Acid TestingFatigueFemaleFeverHumansLength of StayMaleMiddle AgedRetrospective StudiesReverse Transcriptase Polymerase Chain ReactionRNA, ViralCOVID-19ManagementOutcomeRe-hospitalizationSARS-CoV-2

Identifiers

PMID33447913
PMCPMC7808928

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.